3E0M30YIntroduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach

Administration›Physiological Systems and Anatomical Regions›Introduction

Billable / Specific Code

ICD-10-PCS 3E0M30Y

CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.

3E0M30Y is a billable ICD-10-PCS procedure code for Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Code Identity

ICD-10-PCS Code

3E0M30Y

Billable Status

Yes — Valid for Submission

Code Describes

Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach

Parent Code

3E0

Short Description

Introduce Hyperthermic Antneo in Periton Cav, Perc

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

Position	Designation	Value	Meaning
1	Section	3	Administration
2	Body System	E	Physiological Systems and Anatomical Regions
3	Operation	0	Introduction
4	BodySystem/Region	M	Peritoneal Cavity
5	Approach	3	Percutaneous
6	Substance	0	Antineoplastic
7	Qualifier	Y	Hyperthermic

Code History

Replaces previously assigned code(s):

3E0M305 — Introduce Oth Antineoplastic in Periton Cav, Perc

Similar Procedure Codes

Filter related codes list:

Questions About 3E0M30Y

Is 3E0M30Y a billable code?

Yes. 3E0M30Y is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in 3E0M30Y mean?

3E0M30Y breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character M is the BodySystem/Region (Peritoneal Cavity); the 5th character 3 is the Approach (Percutaneous); the 6th character 0 is the Substance (Antineoplastic); the 7th character Y is the Qualifier (Hyperthermic).